子宮頸がんにおけるパリティとヒトパピローマウイルスの役割:IARCの多中心的症例対照研究
Nubia Muñoz1, Silvia Franceschi, Cristina Bosetti
1Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 Cours Albert Thomas, F-69372, Cédex 08, Lyon, France. munoz@iarc.fr
Lancet (London, England)
|April 12, 2002
まとめ
高精度または多くの妊娠は,ヒトパピローマウイルス (HPV) 感染の女性において,状細胞性子宮頸がんのリスクを大幅に増加させます. この発見は,最近,子宮頸がん率の減少を説明するのに役立つかもしれない.
科学分野:
- 婦人科 婦人科について
- 腫瘍学 腫瘍学
- エピデミオロジー エピデミオロジー
背景:
- 高いパリティは,歴史的に,子宮頸がんのリスクの増加と関連しています.
- 以前の研究では,ヒトパピローマウイルス (HPV) の重要な役割について十分に説明できませんでした.
- この研究は,子宮頸がんへのHPVの進行に影響を与える生殖要因に焦点を当てています.
研究 の 目的:
- 高パリティと子宮頸がんリスクの関連性を,特にHPV陽性女性で調査する.
- 状細胞性子宮頸がんの発症における生殖歴の役割を明らかにする.
- パリティがアデノカルシノーマまたはアデノスクワムスカルシノーマのリスクを影響するかどうかを評価する.
主な方法:
- 侵襲性子宮頸がん (ICC) に関する8件のケース・コントロール研究と,イン・シトゥ癌 (ISC) に関する2件のケース・コントロール研究を総合分析した.
- 1465件のICC,211件のISC,124件のアデノカルシノマ/アデノスクワムスICC症例,および255件のHPV陽性対照を含む.
- 無条件マルチロジスティック回帰を使用して,混乱要因を調整して,プールされたオッズ比率を計算しました.
主要な成果:
- 完全妊娠の数と状細胞子宮頸がんのリスクとの間には直接的な関連性が見られた.
- 7回またはそれ以上の満期妊娠をした女性は,無妊娠女性と比較して,オッズ比率が3.8 (95%CI 2.7-5.5) であった.
- パリティとアデノカルシノーマまたはアデノスクワムスカルシノーマのリスクとの間に有意な関連性は観察されなかった.
結論:
- 高いパリティは,HPV陽性女性における状細胞性子宮頸がんの重要な危険因子である.
- 観察された関連は,子宮頸がん発生における生殖歴とHPVの相互作用を強調しています.
- 平均パリティの潜在的低下は,世界的に観察された子宮頸がん発生率の減少に寄与する可能性がある.
関連する概念動画
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...


